Citizens Financial Group Inc Cooper Companies, Inc. Transaction History

Citizens Financial Group Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$280.08 - $347.78 $42,292 - $52,514	-151 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$270.93 - $320.3 $69,358 - $81,996	-256 Reduced 62.9%	151 $43,000
Q1 2020 May 08, 2020	SELL	$243.44 - $359.98 $4,868 - $7,199	-20 Reduced 4.68%	407 $112,000
Q4 2019 Feb 07, 2020	BUY	$281.18 - $322.05 $110,503 - $126,565	393 Added 1155.88%	427 $137,000
Q2 2019 Aug 09, 2019	BUY	$279.29 - $336.89 $9,495 - $11,454	34 New	34 $11,000
Q3 2017 Nov 13, 2017	SELL	$231.6 - $253.39 $6,021 - $6,588	-26 Closed	0 $0
Q2 2017 Aug 10, 2017	BUY	N/A	26	26 $6,000

1.59M

Ticker COO
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 49,346,000
Market Cap $4.51B
Description
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...

Get notified when there are updates to the investment portfolio of Citizens Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Citizens Financial Group Inc with notifications on news.